第 1 到 66 筆結果,共 66 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections | Chen, Tao; Chen, Guang; Wang, Guiqiang; Treeprasertsuk, Sombat; Lesmana, Cosmas Rinaldi Adithya; Lin, Han-Chieh; Al-Mahtab, Mamun; Chawla, Yogesh K; Tan, Soek-Siam; JIA-HORNG KAO ; Yuen, Man-Fung; Lee, Guan-Huei; Alcantara-Payawal, Diana; Nakayama, Nobuaki; Abbas, Zaigham; Jafri, Wasim; Kim, Dong-Joon; Choudhury, Ashok; Mahiwall, Rakhi; Hou, Jinlin; Hamid, Saeed; Jia, Jidong; Bajaj, J S; Wang, Fusheng; Sarin, Shiv K; Ning, Qin | Hepatology international | |||
2 | 2022 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
3 | 2022 | Looking Into the Crystal Ball: A Novel Biomarker for Outcomes of Patients With Chronic Hepatitis B Virus Infection | TAI-CHUNG TSENG ; Wu J.-W.; JIA-HORNG KAO | Hepatology Communications | 0 | 0 | |
4 | 2021 | What we have learned from COVID-19 pandemic? | Chen, Tony Hsiu Hsi ; JIA-HORNG KAO ; JIN-SHING CHEN ; YEN-HSUAN NI | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
5 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
6 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
7 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
8 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
9 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
10 | 2021 | Last Mile to Microelimination of Hepatitis C Virus Infection Among People Living With Human Immunodeficiency Virus | CHEN-HUA LIU ; JIA-HORNG KAO | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 7 | 6 | |
11 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
12 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
13 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
14 | 2021 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
15 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
16 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
17 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
18 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
19 | 2020 | HIGHLIGHTS | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
20 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
21 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
22 | 2020 | The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease | Eslam M.; Sarin S.K.; Wong V.W.-S.; Fan J.-G.; Kawaguchi T.; Ahn S.H.; Zheng M.-H.; Shiha G.; Yilmaz Y.; Gani R.; Alam S.; Dan Y.Y.; JIA-HORNG KAO ; Hamid S.; Cua I.H.; Chan W.-K.; Payawal D.; Tan S.-S.; Tanwandee T.; Adams L.A.; Kumar M.; Omata M.; George J. | Hepatology International | 393 | 339 | |
23 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
24 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
25 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
26 | 2020 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
27 | 2020 | Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply | Estes C.; Chan H.L.Y.; Chien R.N.; Chuang W.-L.; Fung J.; Goh G.B.-B.; Hu T.H.; Huang J.-F.; Jang B.K.; Jun D.W.; JIA-HORNG KAO ; Lee J.-W.; Lin H.-C.; Razavi-Shearer K.; Seto W.-K.; Wong G.L.H.; Wong V.W.S.; Razavi H. | Alimentary Pharmacology and Therapeutics | 1 | 0 | |
28 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
29 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
30 | 2019 | Editorial: nephrotoxicity and oral anti-viral therapy for HBV-facts or fiction? | CHEN-HUA LIU ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 1 | 1 | |
31 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
32 | 2019 | Editorial: comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting anti-viral agents in chronic hepatitis C – authors’ reply | CHEN-HUA LIU ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 0 | 0 | |
33 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
34 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
35 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
36 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
37 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
38 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
39 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
40 | 2019 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
41 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
42 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
43 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
44 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
45 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
46 | 2018 | Prevention of mother-to-child transmission: the key of hepatitis B virus elimination | Lin C.-L.; JIA-HORNG KAO | Hepatology International | 5 | 5 | |
47 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
48 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
49 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 1 | |
50 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
51 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
52 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
53 | 2018 | Highlights | JIA-HORNG KAO | Journal of the Formosan Medical Association | 0 | 0 | |
54 | 2017 | Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace | Lin C.-L.; JIA-HORNG KAO | Hepatology International | 2 | 2 | |
55 | 2017 | Surveillance of hepatocellular carcinoma by magnetic resonance imaging with liver-specific contrast | TUNG-HUNG SU ; JIA-HORNG KAO | JAMA Oncology | 3 | 2 | |
56 | 2016 | Looking into the crystal ball: biomarkers for outcomes of HBV infection | HUNG-CHIH YANG ; JIA-HORNG KAO | Hepatology International | 10 | 10 | |
57 | 2016 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; DING-SHINN CHEN ; HUEY-LING CHEN ; PEI-JER CHEN ; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; CHUN-JEN LIU ; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; JIA-HORNG KAO | Hepatology International | 1819 | 1662 | |
58 | 2016 | Hepatocellular carcinoma recurrence after interferon-free direct acting antiviral treatment for chronic hepatitis C virus infection: Fact or fiction? | CHEN-HUA LIU ; JIA-HORNG KAO | Translational Cancer Research | 2 | 3 | |
59 | 2013 | Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction? | Hsu C.-S.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 2 | 1 | |
60 | 2011 | Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives | CHEN-HUA LIU ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 6 | 6 | |
61 | 2010 | Outcomes of HCV treatment: Who does well and who does not? | Hsu C.-S.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 1 | 1 | |
62 | 2010 | Optimal management of hepatocellular carcinoma: Challenges and opportunities | Lin C.-L.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 8 | 5 | |
63 | 2008 | Universal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone | JIA-HORNG KAO ; DING-SHINN CHEN | American Journal of Medicine | 12 | 12 | |
64 | 2008 | Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations | CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 5 | 5 | |
65 | 2007 | Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges | CHEN-HUA LIU ; CHUN-JEN LIU ; JIA-HORNG KAO | Nephrology | 2 | 7 | |
66 | 2002 | Clinical relevance of hepatitis B viral genotypes: a case of déjà vu? | JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 17 | 16 |